Work

Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions

Year: 2026
Type: review
Abstract: Saponins and their aglycones, the sapogenins, are the bioactive constituents of medicinal herbs such as Panax ginseng and Astragalus membranaceus, and they act on inflammation at several levels at once. The canonical nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), mitogen-activated protein kinase (MAPK), and NLR family pyrin domain-containing 3 (NLRP3) inflammasome cascades are the best-replicated entry points, and beyond them these compounds modify non-coding RNA networks and post-translational regulation and reshape immuno-metabolic circuits by suppressing glycolytic enzymes and engaging AMPK-dependent energy sensing. Whether a given activity belongs to the glycoside or to the aglycone is often unclear, because orally administered glycosides are extensively deglycosylated by the intestinal microbiota, and this review therefore organises the evidence by glycosylation status and annotates every compound accordingly. Translation is constrained by poor aqueous solubility, low and variable bioavailability, structural instability, and dose-dependent toxicity, and stimulus-responsive nanocarriers, exosome-based systems, and microbiota-aware pharmacokinetic modelling are the most credible routes past these barriers. The mechanistic picture that emerges is coherent but still provisional, and progress now depends less on further pathway catalogues than on experiments that establish direct target engagement and on pharmacokinetic-pharmacodynamic data obtained in human-relevant models.
Language: English
Field: Chemistry
Open Access status: hybrid
Estimated APC paid: $4,880
OpenAlex ID: W7234636603
FWCI:
Cites: 64
Cited by:
Related to: 10